Portfolio Companies

Ivy exited in 2008

Auriga Medical Products GmbH located in Zuchwil, Switzerland, was the parent company of Clinical House GmbH, one of Germany’s biggest medical distribution companies. In northern Germany, Clinical House, GmbH was the official exclusive distributor of all SYNTHES® products.

Biomerix Corporation is a medical technology company developing novel devices in endovascular, neurovascular, and orthopedic medicine. The Company's devices utilize a novel, proprietary biomaterial, the Biomerix Reticulated Matrix, a biocompatible, biodurable polyurethane scaffold which has been demonstrated to support tissue ingrowth. Founded in late 2001, Biomerix is currently developing four products addressing an aggregate worldwide market opportunity of approximately $2 billion. The Company's first device, the Biomerix Vascular Occlusion Device, received 510(k) clearance from the U.S. FDA in February 2005. For more information, please visit www.biomerix.com.

Encore Medical Corp. was acquired by Blackstone Capital Partners on November 11, 2006

Encore Medical Corp. headquartered in Austin, Texas engages in the development, manufacture, and distribution of orthopedic devices and related products in the United States. Its products are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries, as well as for at-home physical therapy.

Ivy exited in 2008

Exactech, Inc. headquartered in Gainesville, Florida engages in the development, manufacture, marketing, distribution, and sale of orthopedic implant devices, related surgical instrumentation, and biologic services to hospitals and physicians in the United States and internationally. The Company offers various joint replacement systems, including knee, shoulder, and hip implant systems; and biologic allograft services and bone cement materials used in orthopedic surgery for the repair or replacement of joints. Exactech, Inc. is a publicly-traded company on the NASDAQ under the ticker symbol EXAC.

Gentis, Inc. located in Philadelphia, PA, was formed in June 2000 to commercialize breakthrough technologies for orthopedic treatments emanating from more than a decade of proprietary research work at the Center for Bioactive Materials and Tissue Engineering of the University of Pennsylvania. The Company is developing synthetic products that represent fundamental improvements for treating degenerated intervertebral discs of the spine and other musculoskeletal lesions.

HealthMark Partners, Inc. located in Nashville, TN, acquired Alliance Surgery, Inc. in April 2008. HealthMark develops, owns and operates both inpatient and outpatient ambulatory surgical facilities. By partnering with the best surgeons in the communities in which it operates and focusing its service offerings, HealthMark is able to deliver the highest quality care in the most cost effective setting to its patients.

Company liquidated in October 2009

Highlands Acquisition, Corp. headquartered in Montvale, NJ, was a special purpose acquisition company (SPAC) organized to acquire one or more healthcare operating businesses. The Company was formed as a partnership between Ivy Capital Partners and Kanders & Company, a private investment firm that utilizes a private equity approach to building public companies. Highlands was a publicly-traded company on the AMEX under the ticker symbol HIA.

IVYREHAB Network, Inc., headquartered in Harrison, New York, provides progressive physical therapy in outpatient facilities located throughout the New York, New Jersey and Connecticut tri-state region. The Company’s mission is to maximize the ability of all injured patients to return to their highest level of performance in the shortest and safest possible time. IVYREHAB’s business model promotes an economic partnership between the Company and its director-level therapists in order to attract quality clinicians and ensure that the Company’s goals are properly aligned with those of senior management. IVYREHAB is unconditionally committed to its patients, employees and physician referral base as it recognizes that at the end of the day, “it’s all about the people.”

MAKO Surgical Corp. completed an initial public offering on February 11, 2008 and is listed on the NASDAQ Stock Exchange under the ticker MAKO.

OsteoBiologics, Inc. was acquired by Smith & Nephew plc on July 11, 2006

OsteoBiologics, Inc. located in San Antonio, Texas, develops and manufactures bioabsorbable polymeric scaffolds, films, and related instrumentation for the repair and replacement of bone and articular cartilage. In July 2006, the Company was sold to Smith & Nephew plc for $72.3 million.

ONI Medical Systems, Inc., was acquired by GE Healthcare in November 2009 by way of an asset purchase.

ONI Medical Systems, Inc., headquartered in Wilmington, Massachusetts, develops and markets a family of dedicated purpose MRI systems that offer high-field performance at a low cost. The Company’s first product, the OrthOne® and its new MSK Extreme™, are high-field (1.0 and 1.5 Tesla), dedicated-purpose MRI systems for extremity imaging that provide hospital quality diagnostic images. The OrthOne® and MSK Extreme™ are the only compact design, high-field, truly open configuration extremity MRI systems available in the medical marketplace. Requiring about 200 square feet of floor space, the ONI extremity MRI is easily sited in hospitals, diagnostic imaging centers and orthopedic/sports medicine practices. ONI’s extremity MRI systems also provide a quiet, comfortable, non-claustrophobic experience for patients.

Pivot Medical, Inc., located in Sunnyvale, CA, is a privately held company addressing a large unmet need in non-spine orthopedic areas. For strategic reasons the Company is yet not divulging specific information about their operations or the products they are developing.

ReGen Biologics, Inc. headquartered in Hackensack, NJ, is a publicly traded orthopedics products company that has developed a collagen matrix technology for use in a variety of medical applications. ReGens flagship product, Menaflex collagen meniscus implant (formerly CMI™),is a biologically-derived implant engineered to guide new tissue growth within the meniscus and allow the patient to return to a more active lifestyle.

Scandius Biomedical Inc. was acquired by Covidien Plc on November 8, 2007.

Scandius BioMedical, Inc. headquartered in Littleton, Massachusetts, designs, manufactures, and markets products for the orthopedic sports medicine market. The Company is focused on accelerating innovative solutions for minimally invasive orthopedic sports medicine procedures. With its STRATIS™ ACL Femoral Fixation Implant and its TriTis™ Tibial Fixation System and Implant the Company is able to offer surgeons a complete solution for their soft tissue ACL reconstruction needs. Both technologies offer surgeons a simplified approach to repairing the single most common sports-related orthopedic joint injury - the reconstruction of a torn anterior cruciate ligament. Scandius maintains a strong R&D pipeline focused on procedure specific products that treat a variety of sports-related injuries, with future developments addressing the areas of meniscal repair, articular cartilage and arthroscopic shoulder surgery.

Serica Technologies, Inc. has sold to Allergan, Inc in January 2010 and its orthopedic and veterinary assets were retained and spun into a new company, Alacer Biomedical.

Serica Technologies, Inc. located in Medford, MA is a growth stage medical device company pioneering sophisticated silk-based biomaterial platforms for tissue rejuvenation. Serica's proprietary silk based biomaterial products are currently in pre-clinical and clinical development and are being studied for applications in orthopedics, aesthetic surgery, veternary medicine and other general surgery applications where a mechanical strong, bioresonable tissue scaffold is required.

Spinal Kinetics located in Redwood City, California, is an early stage company developing innovative products used in spinal surgery. The Company is pioneering a new generation of artificial discs for treating Degenerative Disc Disease (DDD) in the cervical and lumbar spine. The Company’s unique technology is designed to replicate a natural vertebral disc in its structure and physiologic range of motion in all planes, including axial compression and rotation. This “natural” artificial disc has been designed to enable patients to move freely while enjoying a sustained quality of life. The Company’s first product is in clinical trials and has not been approved for sale in the U.S.

Stanmore Implants Worldwide Ltd, located north of London in Stanmore, England, is a privately held orthopedic company, focused on saving and restoring the function of limbs and joints. The Company provides patient-specific and standardized orthopedic implants for limb salvage, complex joint replacements and prosthetic attachment. Stanmore Implants was spun-out of the University College of London's Centre for Biomedical Engineering as a vehicle to commercialize the College's intellectual property.